/IRMD

IRadimed Corp

IRMD

$86.17USD↓-0.24%-0.21 today

MARKET CAP

1.1B

P/E (TTM)

44.4x

FWD P/E

36.1x

DAY RANGE

$86 – $88

52W RANGE

$68

$108

AI Summary

Stalk

Sell NowMedium

IRMD is entrenched in a Stage 4 downtrend, marked by a decisive support failure below the 9/20/50 EMAs on high volume. Despite extreme oversold readings, there is no sign of exhaustion or bullish inflection. The dominant bearish pattern indicates accelerating downside, and rallies into the declining EMA ribbon have been consistently rejected. Execution focuses on selling into any short-term bounces up to the EMAs, with a sustained close above that ribbon required to invalidate this bearish bias.

↑Q2 EPS $0.46 vs. $0.44 consensus; net margin 26.7%.
↑FY26 revenue guided $91–96M driven by 3870 pump ramp.
↓High P/E of 48.6x; earnings yield -1.6% signals pricey valuation.

Full analysis →

Buying

5

institutions

Selling

6

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	967.83 K	92.49 M	+38.00	-0.7%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	394.41 K	37.69 M	+-46.30 K	-11.2%	0.05%
TR T. Rowe Price Investment Management, Inc. Q2 2026	BUY	318.68 K	30.45 M	+61.98 K	+23.3%	0.02%
AC Aqr Capital Management LLC Q2 2026	BUY	17.00 K	1.62 M	+1.08 K	+6.0%	0.00%
MG Man Group Plc Q2 2026	BUYNEW	15.85 K	1.51 M	+15.85 K	+0.0%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	11.91 K	1.14 M	+-2.41 K	-17.4%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	11.97 K	1.13 M	+-17.65 K	-60.0%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	9.70 K	926.93 K	+-43.30 K	-81.8%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	6.20 K	595.85 K	+3.10 K	+97.4%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	119.00	11.37 K	+-26.00	-18.5%	0.00%
MM Millennium Management LLC Q2 2026	SELL	0.00	0.00	+-40.51 K	-100.0%	0.00%